Cardiopediatric Home Monitoring Tool

NANot yet recruitingINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

September 11, 2025

Primary Completion Date

December 11, 2027

Study Completion Date

December 11, 2027

Conditions
Congenital Heart Defect
Interventions
OTHER

Home monitoring

"The key parameters (heart rate, arterial oxygen saturation, weight) will be measured at home using the measurement tools used by the parents, and tele-transmitted at a discontinuous rate, i.e. once a day for 4 weeks, then once a week for 20 weeks. The measurement tools will be given to the family before discharge from the hospital ward. These parameters will be entered into the Exolis platform, in addition to a very brief questionnaire designed to provide information about the child's diet, muscle tone and any medication he or she is taking. taken by the child.~An alert will be automatically generated for the pediatric cardiology team if the data transmitted by the measurement sensors deviates from an individualized standard, defined for each child and/or each care pathway at the multidisciplinary consultation meeting before the child returns home.~The response will be standardized on the basis of a protocol shared by the 4 investigating centers."

OTHER

usual medical monitoring

"During the first 4 weeks: a weekly consultation including a record of intercurrent events (malaise, cyanosis, hyperthermia, eating difficulties), a record of weight and vital constants (oxygen saturation, heart rate), an examination of the sternotomy or thoracotomy scar, a clinical cardiovascular examination, a 12-lead electrocardiogram and a transthoracic echocardiogram.~During the following 20 weeks: a consultation at 1, 3 and 6 months including the same assessment procedures."

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT06741189 - Cardiopediatric Home Monitoring Tool | Biotech Hunter | Biotech Hunter